Your browser doesn't support javascript.
loading
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study.
Stathis, Anastasios; Flinn, Ian W; Madan, Sumit; Maddocks, Kami; Freedman, Arnold; Weitman, Steven; Zucca, Emanuele; Munteanu, Mihaela C; Lia Palomba, M.
Afiliación
  • Stathis A; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. Anastasios.Stathis@eoc.ch.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Madan S; Institute for Drug Development, San Antonio, TX, USA.
  • Maddocks K; Ohio State University, Columbus, OH, USA.
  • Freedman A; Dana Farber Cancer Institute, Boston, MA, USA.
  • Weitman S; Institute for Drug Development, San Antonio, TX, USA.
  • Zucca E; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
  • Munteanu MC; ImmunoGen Inc., Waltham, MA, USA.
  • Lia Palomba M; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Invest New Drugs ; 36(5): 869-876, 2018 10.
Article en En | MEDLINE | ID: mdl-29453628
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Inmunoconjugados / Anticuerpos Monoclonales Humanizados / Tetraspaninas / Antineoplásicos Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2018 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Inmunoconjugados / Anticuerpos Monoclonales Humanizados / Tetraspaninas / Antineoplásicos Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2018 Tipo del documento: Article País de afiliación: Suiza